Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline

N Yarom, CL Shapiro, DE Peterson… - Journal of Clinical …, 2019 - pure.au.dk
PURPOSE To provide guidance regarding best practices in the prevention and management
of medicationrelated osteonecrosis of the jaw (MRONJ) in patients with cancer. METHODS …

Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients

…, S Taicher, S Elad, I Hardan, N Yarom - Journal of Oral and …, 2009 - Elsevier
PURPOSE: Osteonecrosis of the jaw (ONJ) is a devastating side effect of long-term bisphosphonate
(BP) use. We present the largest case series from a single department. MATERIALS …

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

S Elad, KKF Cheng, RV Lalla, N Yarom, C Hong… - Cancer, 2020 - Wiley Online Library
Background Mucositis is a significant toxicity of cancer therapy with numerous systemic
sequelae. The goal of this systematic review was to update the Multinational Association of …

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

S Elad, N Yarom, Y Zadik… - CA: a cancer journal …, 2022 - Wiley Online Library
Oral mucositis (OM) is a common, highly symptomatic complication of cancer therapy that
affects patients' function, quality of life, and ability to tolerate treatment. In certain patients with …

Possible association between diabetes and bisphosphonate-related jaw osteonecrosis

M Khamaisi, E Regev, N Yarom, B Avni… - The Journal of …, 2007 - academic.oup.com
Context: Bisphosphonate-related osteonecrosis (BON) of the jaws is a newly identified condition
for which the exact mechanism involved in its pathogenesis remains obscure. Objective: …

[HTML][HTML] Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the …

…, MA Stokman, S Vokurka, E Wallhult, N Yarom… - Supportive Care in …, 2015 - Springer
Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem
cell transplantation (HSCT) recipients are at risk for oral complications which may cause …

Bisphosphonate-related osteonecrosis of the jaw associated with dental implants

…, S Taicher, D Schwartz-Arad, O Peleg, N Yarom - Journal of Oral and …, 2010 - Elsevier
PURPOSE: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a well-documented
devastating side effect of long-term bisphosphonate (BP) use. There is scarce information …

[HTML][HTML] Systematic review of natural agents for the management of oral mucositis in cancer patients

N Yarom, A Ariyawardana, A Hovan, A Barasch… - Supportive Care in …, 2013 - Springer
Purpose The aim of this study was to review the available literature and define clinical practice
guidelines for the use of natural agents for the prevention and treatment of oral mucositis. …

Oral Health-Related Quality of Life in Patients with Temporomandibular Disorders.

…, H Avraham, H Chweidan, Y Noam… - Journal of Oral & …, 2015 - search.ebscohost.com
Aims: To measure the oral health-related quality of life (OHRQoL) in patients with
temporomandibular disorders (TMD) compared to controls and analyze its association with various …

Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates

…, N Givol, R Yahalom, S Taicher, N Yarom - Journal of Oral and …, 2010 - Elsevier
PURPOSE: Osteonecrosis of the jaw is a well-documented side effect of bisphosphonate (BP)
use. Attempts have recently been made to predict the development of bisphosphonate-…